4//SEC Filing
MAHONEY RICHARD S. 4
Accession 0001517737-25-000006
CIK 0000883241other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 11:04 AM ET
Size
15.5 KB
Accession
0001517737-25-000006
Insider Transaction Report
Form 4
SYNOPSYS INCSNPS
MAHONEY RICHARD S.
Chief Revenue Officer
Transactions
- Sale
Common Stock
2025-01-15$505.99/sh−10,322$5,222,796→ 7,803 total - Sale
Common Stock
2025-01-15$505.97/sh−4,173$2,111,401→ 7,803 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-01-15−4,173→ 5,365 totalExercise: $354.45From: 2024-02-17Exp: 2030-02-17→ Common Stock (4,173 underlying) - Exercise/Conversion
Common Stock
2025-01-15$319.20/sh+10,322$3,294,782→ 18,125 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-01-15−10,322→ 8,847 totalExercise: $319.20From: 2023-05-31Exp: 2029-05-31→ Common Stock (10,322 underlying) - Exercise/Conversion
Common Stock
2025-01-15$354.45/sh+4,173$1,479,120→ 11,976 total - Sale
Common Stock
2025-01-15$506.07/sh−6,343$3,210,008→ 1,460 total
Footnotes (4)
- [F1]Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $501.74 to $508.60. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $501.74 to $509.00. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted September 13, 2024.
- [F4]1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
Documents
Issuer
SYNOPSYS INC
CIK 0000883241
Entity typeother
Related Parties
1- filerCIK 0001693085
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 11:04 AM ET
- Size
- 15.5 KB